Evidence map›Paper›PMID 24095990›Full record

ArticleNeuropharmacology2014

[¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.

Jinhua Wu, David C Perry, James E Bupp, Faming Jiang, Willma E Polgar, Lawrence Toll, Nurulain T Zaveri

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Selective αInternational journal of molecular sciences · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jinhua WuTorrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA.
David C PerryDepartment of Pharmacology & Physiology, George Washington University, 2300 Eye St NW, Washington, DC 20037, USA.
James E BuppSRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA.
Faming JiangAstraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, CA 94043, USA.
Willma E PolgarSRI International, 333 Ravenswood Ave., Menlo Park, CA 94025, USA.
Lawrence TollTorrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA.
Nurulain T ZaveriAstraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, CA 94043, USA. Electronic address: nurulain@astraeatherapeutics.com.
Astraea Therapeutics (United States) · USSRI International · USTorrey Pines Institute For Molecular Studies · USGeorge Washington University · US

Funding

Subtype-Selective Nicotinic Receptor Ligands as Smoking Cessation PharmacotherapyR01DA020811 · NIDA · SRI INTERNATIONAL · PI TOLL, LAWRENCE R · 2006 to 2010
$2.0M
PRECLINICAL DEVELOPMENT OF NOVEL SMOKING CESSATION PHARMACOTHERAPIESR44DA033744 · NIDA · ASTRAEA THERAPEUTICS, LLC · PI ZAVERI, NURULAIN T · 2014 to 2016
$1.5M
Development of Novel Drugs for Smoking Cessation PharmacotherapyR43DA033744 · NIDA · ASTRAEA THERAPEUTICS, LLC · PI ZAVERI, NURULAIN T · 2012 to 2012
$293k
NIDA NIH HHS R01 DA020811NIDA NIH HHS R01DA020811NIDA NIH HHS R43 DA033744NIDA NIH HHS R43DA033744NIDA NIH HHS R44 DA033744
6 · The paper itself

Abstract

Recent genetic and pharmacological studies have implicated the α3, β4 and α5 subunits of the nicotinic acetylcholine receptor (nAChR) in dependence to nicotine and other abused drugs and nicotine withdrawal. The α3β4* nAChR subtype has been shown to co-assemble with the α5 or β3 nAChR subunits, and is found mainly in the autonomic ganglia and select brain regions. It has been difficult to study the α3β4 nAChR because there have been no selective nonpeptidic ligands available to independently examine its pharmacology. We recently reported the synthesis of a [(125)I]-radiolabeled analog of a high affinity, selective small-molecule α3β4 nAChR ligand, AT-1012. We report here the vitro characterization of this radioligand in receptor binding and in vitro autoradiographic studies targeting the α3β4* nAChR. Binding of [(125)I]AT-1012 was characterized at the rat α3β4 and α4β2 nAChR transfected into HEK cells, as well as at the human α3β4α5 nAChR in HEK cells. Binding affinity of [(125)I]AT-1012 at the rat α3β4 nAChR was 1.4 nM, with a B(max) of 10.3 pmol/mg protein, similar to what was determined for unlabeled AT-1012 using [(3)H]epibatidine. Saturation isotherms suggested that [(125)I]AT-1012 binds to a single site on the α3β4 nAChR. Similar high binding affinity was also observed for [(125)I]AT-1012 at the human α3β4α5 nAChR transfected into HEK cells. [(125)I]AT-1012 did not bind with high affinity to membranes from α4β2 nAChR-transfected HEK cells. Binding studies with [(3)H]epibatidine further confirmed that AT-1012 had over 100-fold binding selectivity for α3β4 over α4β2 nAChR. K(i) values determined for known nAChR compounds using [(125)I]AT-1012 as radioligand were comparable to those obtained with [(3)H]epibatidine. [(125)I]AT-1012 was also used to label α3β4 nAChR in rat brain slices in vitro using autoradiography, which showed highly localized binding of the radioligand in brain regions consistent with the discreet localization of the α3β4 nAChR. We demonstrate that [(125)I]AT-1012 is an excellent tool for labeling the α3β4 nAChR in the presence of other nAChR subtypes.

Indexed as

LigandsAniline CompoundsAnimalsAutoradiographyFemaleHEK293 CellsHumansMaleProtein BindingRadioligand AssayRatsRats, Sprague-DawleyReceptors, NicotinicTropanesAniline CompoundsAT-1012Ligandsnicotinic receptor alpha3beta4Receptors, NicotinicTropanesAlpha3beta4AT-1012In vitro autoradiographyNicotinic acetylcholine receptorReceptor binding

Identifiers

PMID24095990
PMCPMC3866371
OpenAlexW2072016100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.